| Dr Karen Parks Rudolph, MD | |
|
2108 E 3rd Street, Chattanooga, TN 37404-1622 | |
| (423) 267-0466 | |
| Not Available |
| Full Name | Dr Karen Parks Rudolph |
|---|---|
| Gender | Female |
| Speciality | Vascular Surgery |
| Experience | 12 Years |
| Location | 2108 E 3rd Street, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578838629 | NPI | - | NPPES |
| 59639 | Other | TN | TN MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 59639 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntsville Hospital | Huntsville, AL | Hospital |
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Vascular Consultants Pc | 5092994137 | 6 |
News Archive
Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.
A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital has developed a technique that someday may allow growth of transplantable replacement livers. In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
ARIAD Pharmaceuticals, Inc. today announced the presentation of preclinical data on ponatinib (Iclusig) , at the American Association for Cancer Research Annual Meeting 2013, in Washington.
Medical Marijuana, Inc. endorsed today the unprecedented act of President Obama signing into federal law the removal of restrictions on the use of medical marijuana in the nation's capitol, which underscores MJNA's foresight in becoming the first US public company to emerge, providing solutions to this revolutionary growth industry.
› Verified 7 days ago
| Entity Name | Valley Vascular Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306155460 PECOS PAC ID: 5092994137 Enrollment ID: O20110121000608 |
News Archive
Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.
A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital has developed a technique that someday may allow growth of transplantable replacement livers. In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
ARIAD Pharmaceuticals, Inc. today announced the presentation of preclinical data on ponatinib (Iclusig) , at the American Association for Cancer Research Annual Meeting 2013, in Washington.
Medical Marijuana, Inc. endorsed today the unprecedented act of President Obama signing into federal law the removal of restrictions on the use of medical marijuana in the nation's capitol, which underscores MJNA's foresight in becoming the first US public company to emerge, providing solutions to this revolutionary growth industry.
› Verified 7 days ago
| Entity Name | Valley Vascular Access Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659905610 PECOS PAC ID: 4789015991 Enrollment ID: O20200502000002 |
News Archive
Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.
A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital has developed a technique that someday may allow growth of transplantable replacement livers. In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
ARIAD Pharmaceuticals, Inc. today announced the presentation of preclinical data on ponatinib (Iclusig) , at the American Association for Cancer Research Annual Meeting 2013, in Washington.
Medical Marijuana, Inc. endorsed today the unprecedented act of President Obama signing into federal law the removal of restrictions on the use of medical marijuana in the nation's capitol, which underscores MJNA's foresight in becoming the first US public company to emerge, providing solutions to this revolutionary growth industry.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Parks Rudolph, MD 979 E 3rd St Ste 300, Chattanooga, TN 37403-2187 Ph: (423) 267-0466 | Dr Karen Parks Rudolph, MD 2108 E 3rd Street, Chattanooga, TN 37404-1622 Ph: (423) 267-0466 |
News Archive
Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to evaluate the therapeutic approach of anti-PD-1 in combination with one or both of Aduro's vaccine technologies based on live, attenuated Listeria monocytogenes and STING-activating adjuvants.
A team led by researchers from the Center for Engineering in Medicine at Massachusetts General Hospital has developed a technique that someday may allow growth of transplantable replacement livers. In their report that will be published in Nature Medicine and is receiving early online release, the investigators describe using the structural tissue of rat livers as scaffolding for the growth of tissue regenerated from liver cells introduced through a novel reseeding process.
The first award under BioCurate's new "Proof of Concept" fund has been granted to the Monash Biomedicine Discovery Institute.
ARIAD Pharmaceuticals, Inc. today announced the presentation of preclinical data on ponatinib (Iclusig) , at the American Association for Cancer Research Annual Meeting 2013, in Washington.
Medical Marijuana, Inc. endorsed today the unprecedented act of President Obama signing into federal law the removal of restrictions on the use of medical marijuana in the nation's capitol, which underscores MJNA's foresight in becoming the first US public company to emerge, providing solutions to this revolutionary growth industry.
› Verified 7 days ago
Dr. Julie Ann Koffron, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2108 E 3rd St Ste 200, Chattanooga, TN 37404 Phone: 423-267-0466 Fax: 423-778-5177 | |
Dr. Daniel Franklin Fisher Jr., M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2108 E 3rd St, Suite 200, Chattanooga, TN 37404 Phone: 423-267-0466 Fax: 423-778-8212 | |
Dr. Jason Paul Rehm, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St, Suite C920, Chattanooga, TN 37403 Phone: 423-756-7134 Fax: 423-763-4571 | |
Dr. Michael Everett Barfield, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2108 E 3rd St Ste 200, Chattanooga, TN 37404 Phone: 423-267-0466 Fax: 423-778-5177 | |
Dr. Cauley W Hayes, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 979 E 3rd St, Suite C920, Chattanooga, TN 37403 Phone: 423-756-7134 Fax: 423-763-4571 | |
William Buckley Lyman, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2108 E 3rd St Ste 200, Chattanooga, TN 37404 Phone: 423-267-0466 | |
Dr. Benjamin W Dart Iv, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St, Ste 300, Chattanooga, TN 37403 Phone: 423-267-0466 Fax: 423-757-0775 |